Pulse Biosciences (PLSE) Net Cash Flow (2015 - 2025)

Pulse Biosciences' Net Cash Flow history runs 11 years deep, the most recent figure standing at -$14.5 million for Q4 2025.

• In Q4 2025, Net Cash Flow fell 137.12% year-over-year to -$14.5 million; the TTM figure through Dec 2025 stood at -$37.3 million (down 150.63% YoY), while the FY2025 annual figure was -$37.3 million, down 150.63% from the prior year.
• Net Cash Flow was -$14.5 million for Q4 2025 at Pulse Biosciences, down from -$11.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $54.4 million in Q3 2022 to a low of -$15.9 million in Q1 2022.
• Historically, Net Cash Flow has averaged $3.4 million across 5 years, with a median of -$7.5 million in 2022.
• Biggest YoY gain for Net Cash Flow was 4813.99% in 2021; the steepest drop was 348.04% in 2021.
• A 5-year view of Net Cash Flow shows it stood at -$13.4 million in 2021, then surged by 40.02% to -$8.0 million in 2022, then increased by 24.95% to -$6.0 million in 2023, then jumped by 747.82% to $39.0 million in 2024, then tumbled by 137.12% to -$14.5 million in 2025.
• The last three Net Cash Flow figures came in at -$14.5 million (Q4 2025), -$11.1 million (Q3 2025), and -$12.9 million (Q2 2025), per Business Quant data.